Dr. Andrew Rut, CEO of MyMeds&Me speaks to The Pharma Letter on tech-based pharmacovigilance firms and why they are looking to Japan for new opportunities.
Read more here: https://www.thepharmaletter.co...
Dr. Andrew Rut, CEO of MyMeds&Me speaks to The Pharma Letter on tech-based pharmacovigilance firms and why they are looking to Japan for new opportunities.
Read more here: https://www.thepharmaletter.co...
To find out more or request a demo fill in the details below: